fda

AMA Update 161: COVID vaccine for kids: My son’s experience with Jesse Ehrenfeld, MD, MPH

On vaccinating his 3-year-old son: Jesse Ehrenfeld, MD, MPH, a practicing anesthesiologist in Milwaukee and the AMA’s new president-elect, shares his family’s vaccine experience with American Medical Association CXO Todd Unger, as well as advice for parents of young kids and tips for doctors on answering questions from vaccine-hesitant parents.
Find COVID vaccine locations near you: https://www.vaccines.gov/search/

Read More

AMA Update 158: FDA and CDC back COVID vaccines for youngest kids with Andrea Garcia, JD, MPH

AMA CXO Todd Unger discusses the latest on COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering progress on Moderna’s and Pfizer’s EUAs, and identifying questions parents might have for physicians about getting their kids vaccinated.

Read More

AMA Update 155: Fourth dose boosters and pediatric vaccines, an update with Peter Marks, MD, PhD from the FDA

Hear the latest on who should receive the fourth dose of the COVID-19 booster—and when—and whether we’ll be seeing a vaccine for younger children soon. Susan R. Bailey, MD, immediate past president, AMA welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), addressing a host of hot topics related to the fourth dose booster vaccine and provide updates on pediatric vaccine safety data.

Read More

AMA Update 151: Paxlovid side effects, treatment timelines and more with John Farley, MD, MPH

AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.

For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers

Read More

AMA Update 149: COVID vaccines for kids under 5 with Paul Offit, MD

AMA CXO Todd Unger discusses the status of Covid vaccines for kids under 5 with Paul Offit, MD, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. Dr. Offit is also a member of the FDA’s vaccine advisory committee.

Read More

AMA Update 148: The latest from the FDA on second booster shots and more with Susan R. Bailey, MD

AMA CXO Todd Unger chats with AMA’s immediate past president, Susan Bailey, MD, about big takeaways from her recent conversation with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the FDA. Their talk covered COVID-19 second dose boosters and pediatric vaccines.

Read More

AMA Update 146: FDA to review COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.

Read More

AMA Update 142: Which airlines and public transit require masks with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.

Read More

AMA Update 140: Vaccine trials ramp up for possible fourth dose in fall with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.

Read More

AMA Update 138: Latest guidance from FDA & CDC on second booster shots with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of the BA2 variant, Medicare paying for at-home COVID tests, as well as the latest from the FDA and CDC regarding who may get a second COVID booster shot.

Read More